Thermo Fisher Scientific expands diagnostics portfolio to support full qPCR assay development and testing workflow
Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases
Both companies aim to improve the efficiency and success rate of the current drug discovery process.
Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI
Partnership discussions focus on clinical validation, real-world evidence generation and adoption of indigenous diagnostic technologies across healthcare settings
Advanced molecular diagnostics solution enables rapid, high-accuracy biomarker detection for precision oncology
We are building the bridge between complex molecular data and everyday clinical decisions
Novel fluorescent nanosensor enables real-time detection of indole-3-propionic acid (IPA), paving the way for faster gut health screening, point-of-care diagnostics, and wearable monitoring devices
First-in-human study of investigational SOS1 inhibitor shows encouraging safety profile and early anti-tumor activity in patients with metastatic solid tumors
The newly licensed platform enables precise control over both the drug-to-antibody ratio and payload attachment sites in single- and dual-payload ADCs
Subscribe To Our Newsletter & Stay Updated
